feed,title,long_url,short_url
Benzinga,"Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge",https://benzinga.com/general/biotech/23/02/30877370/frequency-therapeutics-lead-hearing-loss-program-flunks-shifts-focus-to-multiple-sclerosis-shares,https://da.gd/NQC4l
